Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON
  1. Homepage
  2. Equities
  3. Canada
  4. CANADIAN NATIONAL STOCK EXCHANGE
  5. Mindset Pharma Inc.
  6. News
  7. Most relevant
    MSET   CA60268M1023

MINDSET PHARMA INC.

(MSET)
SummaryQuotesChartsNewsCompanyFinancials 
SummaryMost relevantAll NewsOther languagesPress ReleasesOfficial PublicationsSector news
Most relevant news about MINDSET PHARMA INC.
10/14MINDSET PHARMA : Expands Benchmarking Data for First Generation Psychedelics Through the C..
AQ
10/14Mindset Pharma Expands Benchmarking Data for First Generation Psychedelics Through the ..
CI
10/11KCSA Psychedelics Virtual Investor Conference Agenda Announced for October 13th & 14th
AQ
09/29MINDSET PHARMA EXPANDS PIPELINE : Identifies Additional Next Generation 5-MeO-DMT-Inspired..
GL
09/29Mindset Pharma Expands Pipeline Identifies Additional Next Generation 5-MeO-DMT-Inspire..
CI
09/23Mindset Pharma Announces Inclusion in NYSE Listed AdvisorShares Psychedelics Exchange T..
GL
09/20Mindset Pharma Announces Further Preclinical Results Demonstrating Strong Efficacy and ..
GL
09/20Mindset Pharma Inc. Announces Further Preclinical Results Demonstrating Strong Efficacy..
CI
09/14MINDSET PHARMA : Further Validates Lead Candidate as Next Generation Psilocybin Analog Thr..
MT
09/14MINDSET PHARMA : Further Validates Lead Candidate, MSP-1014, as a Next Generation Psilocyb..
AQ
09/09Mindset Pharma Selects Treatment-Resistant Depression and End of Life Cancer Angst as I..
GL
09/07Mindset Pharma Develops Highly Specialized Preclinical Rodent Trained Studies with Its ..
GL
09/07Mindset Pharma Develops Highly Specialized Preclinical Rodent Trained Studies with Its ..
CI
09/02MINDSET PHARMA : to Participate in Upcoming Investor Conferences in September 2021
AQ
08/31Mindset Pharma Announces its Next Generation Novel 5-MeO-DMT Psychedelic Analogs Demons..
GL
08/31Mindset Pharma Inc. Announces Next Generation Novel 5-Meo-Dmt Psychedelic Analogs Demon..
CI
08/26MINDSET PHARMA : Announces Preclinical Results Demonstrating Extended Duration of Action i..
AQ
08/26Mindset Pharma Announces Preclinical Results Demonstrating Extended Duration of Action ..
CI
08/24MINDSET PHARMA : Broadens its IP Portfolio by Filing U.S. Provisional Patent Extending its..
AQ
08/24Mindset Pharma Inc. Files its New Provisional Patent Application with the United States..
CI
08/16MINDSET PHARMA : Announces Publication of Three PCT Patent Applications for Its Next Gener..
AQ
08/16Mindset Pharma Announces Publication of Three PCT Patent Applications for Its Next Gene..
CI
08/10Mindset Pharma Announces Preclinical Results Demonstrating Superior Efficacy, Safety an..
GL
08/10Mindset Pharma Announces Preclinical Results Demonstrating Superior Efficacy, Safety an..
CI
08/03MINDSET PHARMA : Files International Patent Application for its Novel Psilocybin Synthesis..
AQ
08/03Mindset Pharma Inc. Files International Patent Application for Its Novel Psilocybin Syn..
CI
07/20Mindset Pharma Announces Appointment of Clinician Scientist, Dr. Ishrat Husain, to Scie..
GL
07/20Mindset Pharma Announces Appointment of Clinician Scientist, Dr. Ishrat Husain, to Scie..
CI
07/07Mindset Pharma Announces Additional Preclinical Results Suggesting Superior Efficacy an..
GL
07/07Mindset Pharma Announces Additional Preclinical Results Suggesting Superior Efficacy an..
CI
06/14Mindset and InterVivo Solutions Announce Availability of First Preclinical Psychedelic ..
GL
06/03MINDSET PHARMA : Selects its Lead Clinical Candidate, MSP-1014, a Next Generation Psychede..
MT
06/03MINDSET PHARMA : Selects its Lead Clinical Candidate, MSP-1014, a Next Generation Psychede..
AQ
06/03Mindset Selects its Lead Clinical Candidate, MSP-1014, a Next Generation Psychedelic Me..
CI
06/01Mindset Announces Participation at Upcoming Events in June 2021
NE
05/05Mindset Pharma Invited to Present at Canaccord Genuity 41st Annual Growth Conference
NE
04/29Mindset Pharma Inc. Announces Positive Preclinical Results of Its Proprietary Next Gene..
CI
04/29Mindset Pharma Announces Positive Preclinical Results of Its Proprietary Next Generatio..
NE
04/28Mindset Pharma Engages KCSA Strategic Communications to Provide Investor Relations Serv..
NE
04/26Mindset Pharma Invited to Present at H.C. Wainwright "Psychedelics in Psychiatry and Be..
NE
04/20Mindset Pharma Inc. Announces Strong Confirmation of in Vivo Proof-Of-Concept Across it..
CI
04/20Mindset Pharma Announces Strong Confirmation of In Vivo Proof-of-Concept Across Its Ent..
NE
04/19MINDSET PHARMA : Up 13.3% after Reporting Exercise of Over-Allotment Option
MT
04/19Mindset Pharma Announces Exercise of Over-Allotment Option for Additional Gross Proceed..
NE
04/15MINDSET PHARMA : Slips 4.1% after Reporting Closing of $7.5 Million Bought Deal Public Off..
MT
04/15Mindset Pharma Announces Closing of $7.5 Million Bought Deal Public Offering
NE
04/01Mindset Pharma Announces Filing of Amended and Restated FS and MD&A for the Three and S..
NE
03/30Mindset Pharma Inc. Announces Executive Appointments
CI
03/30MINDSET PHARMA EXPANDS SCIENTIFIC TE : Dr. Malik Slassi Appointed Senior VP Innovation and..
NE
03/23Mindset Pharma Inc. Enters A Co-Development Agreement with InterVivo Solutions Inc
CI
03/23Mindset Pharma and InterVivo Solutions to Jointly Develop Advanced Cooperative Psychede..
NE
03/22MINDSET PHARMA : Reports Upsizing of Bought Deal Public Offering
MT
03/22MINDSET PHARMA : IIROC Trade Resumption - MSET
AQ
03/22MINDSET PHARMA : Announces Upsize of Bought Deal to $7.5 Million
AQ
03/22MINDSET PHARMA : IIROC Trading Halt - MSET
AQ
03/22MINDSET PHARMA : Announces $5 Million Bought Deal Financing
AQ
03/17Mindset Pharma Announces DTC Eligibility for OTCQB(R) Venture Listing
NE
03/15Mindset Pharma Inc. Files Sixth U.S. Provisional Patent, Expanding its Psychedelic Drug..
CI
03/15Mindset Pharma Files a Sixth U.S. Provisional Patent, Further Expanding Its Psychedelic..
NE
03/10MINDSET PHARMA TO PRESENT AT THE STI : Addressing the Global Mental Health Crisis
NE
03/08Mindset Pharma Inc. Appoints Joseph Gabriele to Scientific Advisory Board
CI
03/08Mindset Pharma Appoints Leading Molecular Pharmacologist & Formulation Expert Dr. Josep..
NE
02/22Mindset Pharma Reaches Agreement to Manufacture Large Quantity of Pharmaceutical Grade ..
CI
02/10Mindset Pharma Inc. Announces New Drug Program with Proof-Of-Concept Animal Studies of ..
CI
02/05Mindset Files Multiple Final Patent Applications on Its Novel Psilocybin-Inspired Compo..
NE
02/01Mindset Pharma Retains Corporate Development Advisors
NE
02/01Mindset Selects Compounds from Its Third Psilocybin-Inspired Drug Family to Move into i..
CI
02/01Mindset Selects Compounds from Its Third Psilocybin-Inspired Drug Family to Move into i..
NE
01/27Mindset Pharma Announces Listing on the Frankfurt Stock Exchange
NE
01/20Mindset Pharma to Present at Inaugural KCSA Psychedelic Investor Conference
NE
01/14Mindset Pharma Invited to Present at Upcoming Canaccord Genuity Mental Health Conferenc..
NE
01/06Mindset Pharma Inc. Generates Promising in Vitro Results from Third Patent Family of No..
CI
01/06Mindset Generates Promising In Vitro Results from Third Patent Family of Novel Psychede..
NE
2020Mindset Engages Hybrid Financial Inc.
NE
2020Mindset Pharma Inc. Expands Portfolio of Psychedelic Drug Candidates with Third U.S. Pr..
CI
1  2Next